Maltron International Ltd
United Kingdom (ex Northern Ireland) GB-MF-000028357 Last updated 23 May 2026
- Devices
- 1
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
BioScan touch i8 Ref MT950
Related companies
Authorised representatives
What Maltron International Ltd makes
Maltron International Ltd manufactures the BioScan touch i8, a handheld ultrasound imaging device designed for diagnostic evaluations in clinical settings. This device is intended for real-time visualization of internal body structures, supporting applications such as musculoskeletal assessments and soft tissue examinations.
The BioScan touch i8 falls under EU Medical Device Regulation classification as a Class IIa device and is registered in the EU’s eudamed database. The company is based in the United Kingdom.
Frequently asked questions
What types of medical devices does Maltron International Ltd manufacture?
Maltron International Ltd specializes in handheld ultrasound imaging devices. Their primary product, the BioScan touch i8, is designed for real-time diagnostic imaging of internal body structures, such as musculoskeletal assessments and soft tissue examinations. This device is intended for clinical use to aid healthcare professionals in evaluating patients.
Where is Maltron International Ltd based?
Maltron International Ltd is headquartered in the United Kingdom. The company’s location is relevant for regulatory compliance and market access, particularly within the EU, where its devices are registered.
Which regulatory registries list Maltron International Ltd’s devices?
Maltron International Ltd’s devices, including the BioScan touch i8, are listed in the eudamed database. This registry is the official EU database for medical devices, ensuring transparency and traceability under the EU Medical Device Regulation (MDR).
How are Maltron International Ltd’s devices classified under EU regulations?
The BioScan touch i8, manufactured by Maltron International Ltd, is classified as a Class IIa medical device under the EU Medical Device Regulation. This classification is based on its intended use—diagnostic imaging for internal body structures—which carries a moderate risk level requiring specific conformity assessment procedures before market placement.
Information
- Country
- United Kingdom (ex Northern Ireland)
- Address
- 20, Sirdar Road, Essex, United Kingdom (ex Northern Ireland)
- [email protected]
- Phone
- +44 1268778251
- PRRC contact
- Anjum Malik
- EUDAMED SRN
- GB-MF-000028357